November 27, 2024

Syenta, a company founded on technology developed from research at the Australian National University, focuses on revolutionising semiconductor chip manufacturing. The company’s proprietary method, called localised electrochemical modelling, accelerates the advanced packaging process, crucial for high-performance chips used in IoT, AI, and 6G technologies. Unlike traditional photolithography, which is slow and costly, Syenta’s process combines […]

Calumino, founded in 2014 in Sydney, specialises in providing affordable, intelligent infrared sensing technology. The company has developed a unique sensor platform based on micro-optical mechanical systems (MEMS), a subset of semiconductor technology. Unlike traditional infrared sensors, which are either low-resolution and inexpensive or high-quality and costly, Calumino’s sensors offer military-grade performance at a significantly

DeteQt, a Sydney University spin-off founded in 2020, is developing a revolutionary magnetic field sensor using quantum technologies combined with semiconductor innovations. The company’s goal is to create the smallest and most sensitive sensor available. Traditional magnetic field sensors are either too large, expensive, or not sensitive enough for precise applications like navigation. DeteQt’s breakthrough

Feature Panel: Going global – Funding and commercialising Australian innovation on the worldwide stage – Moderator: Nathan Simiana, Deloitte– Marc Kennis, Pitt Street Research– James Berman, Bell Potter– Paula Adamson, Wrays– James Walker, Scalare Partners– Mike Nicholls, Main Sequence Ventures– Pat Stewart, Radium

PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Kidney Disease (PKD) in early 2025. This decision follows the completion of pre-clinical studies demonstrating safety, efficacy, and targeted delivery in animal models and patient-derived kidney cysts. PKD is a genetic disorder that causes

Web Travel Group (ASX:WEB) has reported mixed results for the half-year ending 30 September 2024, its first reporting period since the demerger of its B2C businesses. The demerger, finalised on 30 September, saw Web Travel retain its WebBeds B2B travel marketplace, while Webjet Group, now operating separately, took over the B2C divisions, including Webjet OTA

Web Travel Group (ASX:WEB) has reported mixed results for the half-year ending 30 September 2024, its first reporting period since the demerger of its B2C businesses. The demerger, finalised on 30 September, saw Web Travel retain its WebBeds B2B travel marketplace, while Webjet Group, now operating separately, took over the B2C divisions, including Webjet OTA

VeriQuantix, a new cybersecurity company, specializes in Quantum Link Verification, a cutting-edge technology designed to secure fiber optic communication networks. CEO Peter Baynes highlights the vulnerabilities of current fiber optic systems, especially in the “last mile,” where data breaches often go undetected. The company’s solution uses quantum principles, specifically entangled photons, to verify the trustworthiness

VeriQuantix, a new cybersecurity company, specializes in Quantum Link Verification, a cutting-edge technology designed to secure fiber optic communication networks. CEO Peter Baynes highlights the vulnerabilities of current fiber optic systems, especially in the “last mile,” where data breaches often go undetected. The company’s solution uses quantum principles, specifically entangled photons, to verify the trustworthiness

Novonix (ASX:NVX) has completed a fully underwritten $44.4m institutional placement, issuing approximately 74.1 million new shares at $0.60 each. The placement, aimed at institutional and sophisticated investors, was well-supported by existing shareholders and welcomed several new investors. Chairman Admiral Robert J Natter noted, “The support from institutional shareholders and major backer Phillips 66 highlights confidence